UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 19 Source: CRO
- €1.1 million turnover
-
-€0.6 million
profit - 0 employees
-
31st Dec 18 Source: CRO
- €36.9 million turnover
-
€25.8 million
profit - 1 employees
- 11 more years available »
Ranking
By Turnover
(€1.1 million)- 949th in Top Companies
- 95th in Health
- 83rd in Pharma
By Employees
(0)- 1009th in Top Companies
- 93rd in Health
- 81st in Pharma
-
- 0
- €1.1 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- 11:26am Google uses ‘double-Irish’ to shift $75.4bn in profits out of Ireland
- 5:00am Davy locks local rival Cantor Fitzgerald out of sale process
- 4:58am OECD tax chief says Ireland will need to decide on sensitive issue of 12.5% tax rate
- Apr 16 Aer Lingus faces further cost cuts if summer revenues are lost, chief says
- Apr 16 Carphone Warehouse considers closing its stores in Ireland